|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/05 | |
| A61K 31/352 | |||
| A61K 36/185 | |||
| A61P 35/00 |
| (11) | Number of the document | 3010497 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14732613.6 |
| Date of filing the European patent application | 2014-06-19 | |
| (97) | Date of publication of the European application | 2016-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2014/051888 |
| Date | 2014-06-19 |
| (87) | Number | WO 2014/202989 |
| Date | 2014-12-24 |
| (30) | Number | Date | Country code |
| 201310909 | 2013-06-19 | GB |
| (72) |
LIU, Wai, GB
SCOTT, Katherine, GB
DALGLEISH, Angus, GB
DUNCAN, Marnie, GB
STOTT, Colin, GB
|
| (73) |
GW Research Limited,
Sovereign House, Vision Park Chivers Way, Histon, Cambridge, CB24 9BZ,
GB
|
| (54) | A COMBINATION OF TETRAHYDROCANNABINOL AND CANNABIDIOL FOR USE FOR INCREASING RADIOSENSITIVITY IN THE TREATMENT OF A BRAIN TUMOUR |
| A COMBINATION OF TETRAHYDROCANNABINOL AND CANNABIDIOL FOR USE FOR INCREASING RADIOSENSITIVITY IN THE TREATMENT OF A BRAIN TUMOUR |